12 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With AlbuminuriaAlbuminuria, Body Weight, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, kidney disorder, kidney failure, nutritional disorder, obesity disorder, overnutrition, proteinuria, urinary system disorderNot yet recruitingNot applicable2026-09-30NCT07849348
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor TherapyNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderEnrolling by invitationNot applicable2026-02-13NCT07409298
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyRecruitingNot stated2026-02-11NCT06107582
Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI ClassificationPathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsNot yet recruitingNot stated2025-08-08NCT07111429
Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical StudyPlatinum-resistant Ovarian Cancer (PROC)Not yet recruitingPhase 42025-07-20NCT07075250
Romiplostim N01 for Chemotherapy-induced ThrombocytopeniaChemotherapy-induced Thrombocytopenia; Romiplostim N01RecruitingPhase 22025-07-14NCT07063225
Herombopag for Chemotherapy-induced ThrombocytopeniaChemotherapy-induced Thrombocytopenia; HerombopagRecruitingPhase 22025-02-24NCT05236582
Eltrombopag for Chemotherapy-induced ThrombocytopeniaChemotherapy-induced Thrombocytopenia; EltrombopagRecruitingPhase 22025-02-24NCT04600960
Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological DeficitAtlantoaxial DislocationNot yet recruitingNot stated2025-01-13NCT06772311
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaCytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyActive, not recruitingPhase 22024-12-30NCT06199089
Minimally Invasive Atlantoaxial Lateral Mass Joint Fusion (MIS-PALF) As a Surgical Treatment of Atlantoaxial DislocationAtlantoaxial DislocationNot yet recruitingNot applicable2024-11-07NCT06678711
Surgical Treatment of Irreducible Atlantoaxial DislocationIrreducible Atlantoaxial DislocationRecruitingNot applicable2024-01-08NCT05847270